Advisor Group
TEVA icon

Advisor Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$442K Sell
45,080
-8,559
-16% -$76.4K ﹤0.01% 1762
2019
Q3 		$368K Buy
53,639
+2,264
+4% +$17.3K ﹤0.01% 1837
2019
Q2 		$473K Buy
51,375
+2,101
+4% +$25.3K ﹤0.01% 1656
2019
Q1 		$773K Sell
49,274
-5,948
-11% -$105K 0.01% 1275
2018
Q4 		$851K Buy
55,222
+5,281
+11% +$108K 0.01% 1039
2018
Q3 		$1.08M Buy
49,941
+24,473
+96% +$568K 0.01% 940
2018
Q2 		$620K Sell
25,468
-1,881
-7% -$38.4K 0.01% 1163
2018
Q1 		$467K Buy
27,349
+1,748
+7% +$34.1K 0.01% 1373
2017
Q4 		$484K Sell
25,601
-7,120
-22% -$107K 0.01% 1348
2017
Q3 		$576K Buy
32,721
+8,171
+33% +$184K 0.01% 1110
2017
Q2 		$816K Buy
24,550
+6,067
+33% +$188K 0.01% 857
2017
Q1 		$593K Buy
18,483
+5,106
+38% +$174K 0.01% 973
2016
Q4 		$485K Sell
13,377
-3,331
-20% -$133K 0.01% 1036
2016
Q3 		$769K Buy
16,708
+665
+4% +$34.7K 0.02% 748
2016
Q2 		$803K Buy
+16,043
New +$854K 0.02% 700

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Miller Value Partners
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Advisor Group's TEVA Position: Q4 2019 in Review

Advisor Group reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 16% in Q4 2019, selling an estimated $76.4K and leaving 45,080 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Advisor Group first reported a position in TEVA in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.08M in Q3 2018. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

  • Advisor Group held 45,080 shares of Teva Pharmaceutical Industries Limited worth $442K as of Q4 2019.
  • Advisor Group sold 8,559 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $76.4K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1762 holding.
  • Advisor Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Teva Pharmaceutical Industries Limited position peaked at $1.08M in Q3 2018.
  • 437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.